Protein Sciences uses recombinant DNA technology to produce its vaccines using a single protein from the virus.
CNN: King: H1N1 worries increase awareness on college campuses
The UC System, the NIH and other institutions gave rise to recombinant DNA and a whole new industry.
Genetic engineering, or recombinant DNA, methods can be and are used to create both cisgenic and transgenic constructions.
FORBES: EPA Biotech Regulation Bucks The Scientific Consensus
Biologic drugs are protein-based and derived from living matter or manufactured in living cells using recombinant DNA biotechnologies.
In other words, recombinant DNA techniques were viewed as an extension, or refinement, of long-used and familiar methods for making drugs.
In 1976 biochemist Herb Boyer and venture capitalist Robert Swanson started Genentech around a new technology, recombinant DNA. They created a brand-new industry, biotechnology.
During the past three decades, untold numbers of drugs and diagnostic tests based on recombinant DNA technology have been tested and hundreds have been approved for marketing.
It led him to a faculty job at Johns Hopkins and then, in 1987, to Bayer, where he brought to market the first hemophilia drug ever to use recombinant DNA technology.
The Recombinant DNA Advisory Committee, a division of the National Institutes of Health that approves all gene therapy experiments, has yet to make a decision on whether this technique should move into the clinic.
Not surprisingly, advances in recombinant DNA technology continue.
His main example was Genentech, one of the first companies that attempted to market products based on the revolutionary recombinant DNA technologies that were emerging during the 1970s from the medical labs at Stanford and the University of California, San Francisco.
FORBES: Venture Capitalist Tom Perkins: 'If There Is No Risk, You Have Already Missed the Boat'
应用推荐